TY - JOUR
T1 - "Couple's Immunotherapy"
T2 - Is CXCL13 at the Heart of the Prescription?
AU - Cruz-Hinojoza, Eduardo
AU - Stromnes, Ingunn M.
N1 - Publisher Copyright:
© 2024 American Association for Cancer Research.
PY - 2024/8
Y1 - 2024/8
N2 - Sex differences in cancer survivorship and response to immunotherapy have been observed, with males generally displaying better outcomes to immune checkpoint blockade compared with females. In this article, by interrogating public lung cancer sequencing datasets, Brennan and colleagues uncover a chemokine axis that may contribute to disparate immunotherapy outcomes between the sexes.
AB - Sex differences in cancer survivorship and response to immunotherapy have been observed, with males generally displaying better outcomes to immune checkpoint blockade compared with females. In this article, by interrogating public lung cancer sequencing datasets, Brennan and colleagues uncover a chemokine axis that may contribute to disparate immunotherapy outcomes between the sexes.
UR - http://www.scopus.com/inward/record.url?scp=85200423474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85200423474&partnerID=8YFLogxK
U2 - 10.1158/2326-6066.cir-24-0481
DO - 10.1158/2326-6066.cir-24-0481
M3 - Review article
C2 - 38967231
AN - SCOPUS:85200423474
SN - 2326-6066
VL - 12
SP - 952
EP - 953
JO - Cancer Immunology Research
JF - Cancer Immunology Research
IS - 8
ER -
